Corno C - Search Results

1

Targeting of the Lipid Metabolism Impairs Resistance to BRAF Kinase Inhibitor in Melanoma.

Vergani E, Beretta GL, Aloisi M, Costantino M, Corno C, Frigerio S, Tinelli S, Dugo M, Accattatis FM, Granata A, Arnaboldi L, Rodolfo M, Perego P, Gatti L. Vergani E, et al. Among authors: corno c. Front Cell Dev Biol. 2022 Jul 13;10:927118. doi: 10.3389/fcell.2022.927118. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 35912092 Free PMC article.

2

Drug Combinations with HDAC Inhibitors in Antitumor Therapy.

Arrighetti N, Corno C, Gatti L. Arrighetti N, et al. Among authors: corno c. Crit Rev Oncog. 2015;20(1-2):83-117. doi: 10.1615/critrevoncog.2014012378. Crit Rev Oncog. 2015. PMID: 25746106 Review.

3

Role of the Receptor Tyrosine Kinase Axl and its Targeting in Cancer Cells.

Corno C, Gatti L, Lanzi C, Zaffaroni N, Colombo D, Perego P. Corno C, et al. Curr Med Chem. 2016;23(15):1496-512. doi: 10.2174/0929867323666160405112954. Curr Med Chem. 2016. PMID: 27048336 Free article. Review.

4

Integrin-Targeted Peptide- and Peptidomimetic-Drug Conjugates for the Treatment of Tumors.

Arosio D, Manzoni L, Corno C, Perego P. Arosio D, et al. Among authors: corno c. Recent Pat Anticancer Drug Discov. 2017;12(2):148-168. doi: 10.2174/1574892812666170203151930. Recent Pat Anticancer Drug Discov. 2017. PMID: 28164756 Review.

5

Axl molecular targeting counteracts aggressiveness but not platinum-resistance of ovarian carcinoma cells.

Corno C, Gatti L, Arrighetti N, Carenini N, Zaffaroni N, Lanzi C, Perego P. Corno C, et al. Biochem Pharmacol. 2017 Jul 15;136:40-50. doi: 10.1016/j.bcp.2017.04.002. Epub 2017 Apr 9. Biochem Pharmacol. 2017. PMID: 28404378

6

FoxO-1 contributes to the efficacy of the combination of the XPO1 inhibitor selinexor and cisplatin in ovarian carcinoma preclinical models.

Corno C, Stucchi S, De Cesare M, Carenini N, Stamatakos S, Ciusani E, Minoli L, Scanziani E, Argueta C, Landesman Y, Zaffaroni N, Gatti L, Perego P. Corno C, et al. Biochem Pharmacol. 2018 Jan;147:93-103. doi: 10.1016/j.bcp.2017.11.009. Epub 2017 Nov 16. Biochem Pharmacol. 2018. PMID: 29155058

7

Role of FoxO Proteins in Cellular Response to Antitumor Agents.

Beretta GL, Corno C, Zaffaroni N, Perego P. Beretta GL, et al. Among authors: corno c. Cancers (Basel). 2019 Jan 14;11(1):90. doi: 10.3390/cancers11010090. Cancers (Basel). 2019. PMID: 30646603 Free PMC article. Review.

8

Alterations of RNA Metabolism by Proteomic Analysis of Breast Cancer Cells Exposed to Marycin: A New Optically Active Porphyrin.

Taverna E, De Bortoli M, Maffioli E, Corno C, Ciusani E, Trivulzio S, Pinelli A, Tedeschi G, Perego P, Bongarzone I. Taverna E, et al. Among authors: corno c. Curr Mol Pharmacol. 2019;12(2):147-159. doi: 10.2174/1874467212666190204102112. Curr Mol Pharmacol. 2019. PMID: 30714537

9

KiSS1 in regulation of metastasis and response to antitumor drugs.

Corno C, Perego P. Corno C, et al. Drug Resist Updat. 2019 Jan;42:12-21. doi: 10.1016/j.drup.2019.02.001. Epub 2019 Feb 11. Drug Resist Updat. 2019. PMID: 30776659 Review.

10

Efficacy of a Selective Binder of α_Vβ₃ Integrin Linked to the Tyrosine Kinase Inhibitor Sunitinib in Ovarian Carcinoma Preclinical Models.

Sartori A, Corno C, De Cesare M, Scanziani E, Minoli L, Battistini L, Zanardi F, Perego P. Sartori A, et al. Among authors: corno c. Cancers (Basel). 2019 Apr 13;11(4):531. doi: 10.3390/cancers11040531. Cancers (Basel). 2019. PMID: 31013908 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

53 results

Search Page